Korro Bio, Inc. 是一家生物製藥公司,基於RNA編輯技術發現、開發及商業化基因藥物,用於治療罕見及高度流行疾病。公司總部位於馬薩諸塞州劍橋。
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$1.29M
2025-09-30
$1.09M
營業支出
2026-06-30
$20.11M
2026-03-31
$20.43M
2025-12-31
$16.52M
2025-09-30
$20.32M
淨利潤
2026-06-30
-$18.91M
2026-03-31
-$19.62M
2025-12-31
-$50.04M
2025-09-30
-$18.06M
淨利潤率
2026-06-30
--
2026-03-31
--
2025-12-31
-3.87K%
2025-09-30
-1.65K%
每股收益
2026-06-30
$-1.07
2026-03-31
$-1.69
2025-12-31
$-1.65
2025-09-30
$-1.92
息稅折舊攤銷前利潤
2026-06-30
-$19.74M
2026-03-31
-$20.05M
2025-12-31
-$15.23M
2025-09-30
-$16.88M
有效稅率
2026-06-30
-0.57%
2026-03-31
-0.48%
2025-12-31
-1.28%
2025-09-30
--
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$0
$0
$1.29M
$1.09M
營業支出
$20.11M
$20.43M
$16.52M
$20.32M
淨利潤
-$18.91M
-$19.62M
-$50.04M
-$18.06M
淨利潤率
--
--
-3.87K%
-1.65K%
每股收益
$-1.07
$-1.69
$-1.65
$-1.92
息稅折舊攤銷前利潤
-$19.74M
-$20.05M
-$15.23M
-$16.88M
有效稅率
-0.57%
-0.48%
-1.28%
--
常見問題
KRRO stock represents shares of a publicly traded company. Because the company's specific name and business focus have not been provided, the most accurate way to identify what KRRO stock represents is to check the ticker details, company profile, and exchange listing displayed on the KRRO stock page. That page typically shows the company's sector, headquarters, and principal business activities, giving investors a clearer picture of the underlying business before they research further.
The current price of KRRO stock changes throughout each trading session as buyers and sellers submit orders. Because the latest quote depends on real-time market activity, it should be read directly from the KRRO stock page rather than from a static description. That page typically displays the most recent trade price, along with related data such as daily change and trading volume, so investors can see how KRRO is trading at that moment.
Valuation of KRRO stock usually involves comparing its market price with financial measures such as earnings, sales, book value, and cash flow. Common tools include the price-to-earnings ratio, price-to-sales ratio, and enterprise value multiples, which are most useful when compared with peers in the same industry and with KRRO's own historical averages. Since these figures depend on current market data and reported financials, investors should use the valuation metrics shown on the KRRO stock page.
KRRO stock may be available for trading in pre-market and after-hours sessions, depending on whether it is listed on a major U.S. exchange and whether brokers support extended-hours trading. These sessions usually have lower liquidity, wider bid-ask spreads, and higher price volatility than regular trading hours. Whether KRRO specifically can be traded outside regular hours depends on the exchange and the individual broker's rules, so investors should confirm availability before placing such orders.
Useful metrics for KRRO often include revenue growth, gross and operating margins, net income, earnings per share, free cash flow, debt levels, and return on equity. These measures help investors judge growth, profitability, financial strength, and cash generation. Comparing KRRO's metrics across several quarters and against industry peers can reveal trends that a single figure may hide. The exact values should be taken from KRRO's latest quarterly and annual reports rather than estimated.
Risks for KRRO depend on its industry, business model, financial condition, and market environment. Common risks can include competition, customer concentration, regulatory changes, supply-chain disruptions, debt obligations, and the possibility of weaker-than-expected revenue or earnings. Broader market declines, rising interest rates, and shifts in investor sentiment can also affect KRRO's share price. Reviewing the risk factors in KRRO's annual report and recent filings can help investors understand company-specific exposures.